Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new Revision: v3.4.2 note and removed the previous government-operating-status notice along with the prior Revision: v3.4.1 entry.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide government funding notice indicating potential delays and that the NIH Clinical Center is open, and updated the revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now includes minor UI/label updates and metadata changes: a Show glossary option, capitalization tweaks to QC-related labels, and a new revision tag (v3.4.0), with no changes to core study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 is now shown in the page header, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing participating sites across US states, Australia, and Canada. Updated the page revision to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not all be about the study. Page revision label updated to v3.3.2, replacing the previous v3.2.0 wording.SummaryDifference0.1%

Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.